Niteesh K Choudhry

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials
    Niteesh K Choudhry
    Harvard Medical School and Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Am J Med 118:465-74. 2005
  2. ncbi Systematic review: the relationship between clinical experience and quality of health care
    Niteesh K Choudhry
    Harvard Medical School and Harvard Pilgrim Health Care, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Ann Intern Med 142:260-73. 2005
  3. ncbi A perspective on US drug reimportation
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass 02120, USA
    JAMA 293:358-62. 2005
  4. ncbi State generic substitution laws can lower drug outlays under Medicaid
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 29:1383-90. 2010
  5. ncbi Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Nephrol 25:341-53. 2012
  6. ncbi Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 6:2662-8. 2011
  7. ncbi The impact of reducing cardiovascular medication copayments on health spending and resource utilization
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Coll Cardiol 60:1817-24. 2012
  8. ncbi Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications
    Nihar R Desai
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 125:302.e1-7. 2012
  9. ncbi Modes of delivery for interventions to improve cardiovascular medication adherence
    Sarah L Cutrona
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, USA
    Am J Manag Care 16:929-42. 2010
  10. ncbi Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery
    Alexander Kulik
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Circ Cardiovasc Interv 5:590-6. 2012

Detail Information

Publications77

  1. ncbi How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials
    Niteesh K Choudhry
    Harvard Medical School and Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    Am J Med 118:465-74. 2005
    ..Patients with unstable angina or non-ST-segment elevation myocardial infarction (MI) may be managed with either an "invasive" or "conservative" strategy. It is unclear which of these strategies is superior...
  2. ncbi Systematic review: the relationship between clinical experience and quality of health care
    Niteesh K Choudhry
    Harvard Medical School and Harvard Pilgrim Health Care, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Ann Intern Med 142:260-73. 2005
    ..However, evidence suggests that there is an inverse relationship between the number of years that a physician has been in practice and the quality of care that the physician provides...
  3. ncbi A perspective on US drug reimportation
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass 02120, USA
    JAMA 293:358-62. 2005
  4. ncbi State generic substitution laws can lower drug outlays under Medicaid
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 29:1383-90. 2010
    ..Although these consent requirements are probably intended to increase patient autonomy, policy makers should consider the sizable opportunity costs...
  5. ncbi Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    J Nephrol 25:341-53. 2012
    ..Little is known about the use of warfarin in hemodialysis (HD) patients with atrial fibrillation (AF). We studied temporal trends of AF among older HD patients, and of warfarin use among those with AF...
  6. ncbi Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation
    Wolfgang C Winkelmayer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 6:2662-8. 2011
    ..Although generally recommended in atrial fibrillation (AF) patients, the effectiveness and safety of oral anticoagulation in dialysis patients with AF is unknown...
  7. ncbi The impact of reducing cardiovascular medication copayments on health spending and resource utilization
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Coll Cardiol 60:1817-24. 2012
    ..The aim of this study was to evaluate the impact of reductions in statin and clopidogrel copayments on cardiovascular resource utilization, major coronary events, and insurer spending...
  8. ncbi Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications
    Nihar R Desai
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 125:302.e1-7. 2012
    ..We aimed to evaluate temporal trends in the use of specific drugs for the initial management of type 2 diabetes and to estimate the economic consequences of non-recommended care...
  9. ncbi Modes of delivery for interventions to improve cardiovascular medication adherence
    Sarah L Cutrona
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA, USA
    Am J Manag Care 16:929-42. 2010
    ..To determine the optimal modes of delivery for interventions to improve adherence to cardiovascular medications...
  10. ncbi Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery
    Alexander Kulik
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Circ Cardiovasc Interv 5:590-6. 2012
    ..Controversy exists regarding the optimal preventative therapy for venous thromboembolism (VTE) after coronary artery bypass graft (CABG) surgery. We sought to compare the effectiveness and safety of the most commonly used regimens...
  11. ncbi Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy label
    William H Shrank
    Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street Suite 3030, Boston, MA 02120, USA
    J Gen Intern Med 24:570-8. 2009
    ..A new prescription medication labeling system was implemented by Target pharmacies in May 2005 and aimed to improve readability and understanding...
  12. ncbi Patient, physician, and payment predictors of statin adherence
    David C Chan
    Department of Medicine, Division of General Internal Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Med Care 48:196-202. 2010
    ..Although many patient, physician, and payment predictors of adherence have been described, knowledge of their relative strength and overall ability to explain adherence is limited...
  13. ncbi Full coverage for preventive medications after myocardial infarction
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    N Engl J Med 365:2088-97. 2011
    ..Adherence to medications that are prescribed after myocardial infarction is poor. Eliminating out-of-pocket costs may increase adherence and improve outcomes...
  14. ncbi Warnings without guidance: patient responses to an FDA warning about ezetimibe
    William H Shrank
    Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston 02120, USA
    Med Care 50:479-84. 2012
    ..We investigated the proportion of patients who discontinued therapy and switched to a clinically appropriate alternative after the FDA communication...
  15. ncbi Healthcare information technology interventions to improve cardiovascular and diabetes medication adherence
    Alexander S Misono
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am J Manag Care 16:SP82-92. 2010
    ..To determine the efficacy of healthcare information technology (HIT) interventions in improving adherence...
  16. ncbi Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Circulation 117:1261-8. 2008
    ....
  17. ncbi Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics
    Niteesh K Choudhry
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Massachusetts, USA
    Am J Med 119:607-15. 2006
    ..The study investigated the determinants of warfarin use in patients with atrial fibrillation (AF)...
  18. ncbi Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 17:1189-96. 2008
    ..Poor levels of medication adherence for patients with coronary heart disease (CHD) have been documented but it is unclear whether adherence has improved over time...
  19. ncbi Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial
    William H Shrank
    Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am Heart J 157:613-9. 2009
    ..Highly effective generic cardiovascular medications are frequently underused, leading to greater overall drug costs and cost-related nonadherence...
  20. ncbi Cost-effectiveness of genotype-guided warfarin dosing for patients with atrial fibrillation
    Amanda R Patrick
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Circ Cardiovasc Qual Outcomes 2:429-36. 2009
    ..However, the effectiveness of genotyping in improving anticoagulation control and reducing major bleeding has not yet been compellingly demonstrated. Genotyping currently costs $400 to $550...
  21. ncbi Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction
    Kouta Ito
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Health Serv Res 47:2097-117. 2012
    ..To evaluate the comparative cost-effectiveness of interventions to improve adherence to evidence-based medications among postmyocardial infarction (MI) patients...
  22. ncbi Targeting cardiovascular medication adherence interventions
    Sarah L Cutrona
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, USA
    J Am Pharm Assoc (2003) 52:381-97. 2012
    ..To determine whether adherence interventions should be administered to all medication takers or targeted to nonadherers...
  23. ncbi Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Am Heart J 156:31-6. 2008
    ..Removing patient out-of-pocket drug costs may increase adherence, improve clinical outcomes, and even reduce overall health costs for high-risk patients. The existing data are inadequate to assess whether this strategy is effective...
  24. ncbi Is there a relationship between patient beliefs or communication about generic drugs and medication utilization?
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Med Care 47:319-25. 2009
    ..Insurers and policymakers strive to stimulate more cost-effective prescribing and, increasingly, are educating beneficiaries about generics...
  25. ncbi Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation
    Sebastian Schneeweiss
    Department of Medicine, Harvard Medical School, Boston, MA, USA
    Circ Cardiovasc Qual Outcomes 5:480-6. 2012
    ..We sought to compare the efficacy and safety of the 3 new agents based on data from their published warfarin-controlled randomized trials, using the method of adjusted indirect comparisons...
  26. ncbi The epidemiology of prescriptions abandoned at the pharmacy
    William H Shrank
    Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    Ann Intern Med 153:633-40. 2010
    ..Understanding the epidemiology and correlates of prescription abandonment may have an important effect on health care quality...
  27. ncbi The economic consequences of non-evidence-based clopidogrel use
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Am Heart J 155:904-9. 2008
    ..However, little is known about the appropriateness of that use. Overuse of clopidogrel could have important implications for health care quality and drug expenditures...
  28. ncbi Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization
    Alexander Kulik
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Am J Cardiol 107:1409-14. 2011
    ..Given the health and economic consequences of nonadherence, these findings highlight the need for developing cost-effective strategies to improve medication adherence after coronary revascularization...
  29. ncbi The consequences of requesting "dispense as written"
    William H Shrank
    Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 124:309-17. 2011
    ..Patients also can make these requests. Little is known about the frequency and correlates of dispense as written requests or their association with medication filling...
  30. ncbi The implications of therapeutic complexity on adherence to cardiovascular medications
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Arch Intern Med 171:814-22. 2011
    ..Our objective was to estimate the extent of prescribing and filling complexity in patients prescribed a cardiovascular medication and to evaluate its association with adherence...
  31. ncbi Measuring concurrent adherence to multiple related medications
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am J Manag Care 15:457-64. 2009
    ..To propose standardized methods for measuring concurrent adherence to multiple related medications and to apply these definitions to a cohort of patients with diabetes mellitus...
  32. ncbi Trouble getting started: predictors of primary medication nonadherence
    Michael A Fischer
    Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Am J Med 124:1081.e9-22. 2011
    ..The advent of electronic prescribing (e-prescribing) systems provides the opportunity to track initial prescriptions and identify nonadherence that may have previously been undetected...
  33. ncbi Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review
    Sarah L Cutrona
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Gen Intern Med 25:1090-6. 2010
    ..Medications for the prevention and treatment of cardiovascular disease save lives but adherence is often inadequate. The optimal role for physicians in improving adherence remains unclear...
  34. ncbi The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money
    William H Shrank
    CVS Caremark Harvard Partnership to Improve Medication Adherence, Brigham and Women s Hospital, Boston, MA, USA
    Health Aff (Millwood) 30:1351-7. 2011
    ..As the nation attempts to find strategies to improve population health without adding to the unsustainably high cost of care, policy makers should focus on ensuring that patients have access to essential generic medications...
  35. ncbi Are caregivers adherent to their own medications?
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    J Am Pharm Assoc (2003) 51:492-8. 2011
    ..To explore caregiver adherence to chronic medications and predictors of appropriate medication use...
  36. ncbi A systematic review of adherence to cardiovascular medications in resource-limited settings
    Ashna D K Bowry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    J Gen Intern Med 26:1479-91. 2011
    ..To evaluate prevalence and predictors of non-adherence to cardiovascular medications in this context, we systematically reviewed the peer-reviewed literature...
  37. ncbi Conflict of interest in oncology publications: a survey of disclosure policies and statements
    Aaron S Kesselheim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Cancer 118:188-95. 2012
    ..The authors sought to define current disclosure policies and how they relate to disclosure statements provided by authors in major oncology journals...
  38. ncbi Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004
    Andrea V Margulis
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Pharmacoepidemiol Drug Saf 20:1088-97. 2011
    ....
  39. ncbi The international pharmaceutical market as a source of low-cost prescription drugs for U.S. patients
    Aaron S Kesselheim
    Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Ann Intern Med 148:614-9. 2008
    ....
  40. ncbi Drug company-sponsored patient assistance programs: a viable safety net?
    Niteesh K Choudhry
    Brigham and Women s Hospital BWH, Division of Pharmacoepidemiology and Pharmacoeconomics, in Boston, Massachusetts, USA
    Health Aff (Millwood) 28:827-34. 2009
    ..A better understanding of PAPs might clarify their role in improving access to medications, the adequacy of existing public programs, and their impact on cost-effective medication use...
  41. ncbi Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome
    Jeremy A Rassen
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Boston, MA 02120, USA
    Circulation 120:2322-9. 2009
    ..Recent studies have raised concerns about the reduced efficacy of clopidogrel when used concurrently with proton pump inhibitors (PPIs), but those studies may have overestimated the risk...
  42. ncbi Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis
    Aaron S Kesselheim
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    JAMA 300:2514-26. 2008
    ..Use of generic drugs, which are bioequivalent to brand-name drugs, can help contain prescription drug spending. However, there is concern among patients and physicians that brand-name drugs may be clinically superior to generic drugs...
  43. ncbi Physician perceptions about generic drugs
    William H Shrank
    Brigham and Women s Hospital and Department of Medicine, Division of Pharmacoepidemiology and Pharmacoeconomics, Harvard Medical School, Boston, MA, USA
    Ann Pharmacother 45:31-8. 2011
    ..With constrained health-care resources, there is a need to understand barriers to cost-effective medication use...
  44. ncbi Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02120, USA
    Ann Pharmacother 42:1563-72. 2008
    ..Because of superior safety and lower cost, rate control is now the recommended strategy for the management of most elderly, high-risk AF patients...
  45. ncbi Impact of statin use on outcomes after coronary artery bypass graft surgery
    Alexander Kulik
    Brigham and Women s Hospital, 1620 Tremont St, Suite 3030, Boston, MA 02120, USA
    Circulation 118:1785-92. 2008
    ....
  46. ncbi A cohort study of thiazolidinediones and fractures in older adults with diabetes
    Daniel H Solomon
    Division of Rheumatology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Clin Endocrinol Metab 94:2792-8. 2009
    ..Recent results from several randomized controlled trials find an increased risk of fracture with TZDs compared with other oral antidiabetic agents...
  47. ncbi Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis
    Niteesh K Choudhry
    Harvard Medical School and Brigham and Women s Hospital, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:186-94. 2007
    ..Our analysis suggests that covering combination therapy for such patients will save both lives and money...
  48. ncbi An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    Med Care 47:1031-5. 2009
    ..A new prescription medication labeling system was implemented by Target pharmacies in May 2005 and aimed to improve health outcomes...
  49. ncbi Barriers to insulin progression among patients with type 2 diabetes: a systematic review
    Jennifer M Polinski
    Jennifer M Polinski, ScD, MPH, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA 02120
    Diabetes Educ 39:53-65. 2013
    ..Future studies should use multilevel longitudinal designs to quantify the relative impact of potential patient, provider, and health system factors on progression and health outcomes...
  50. ncbi Preoperative statin use and postoperative acute kidney injury
    Steven M Brunelli
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    Am J Med 125:1195-1204.e3. 2012
    ..The purpose of this study was to evaluate whether preoperative statin use is associated with a decreased risk of postoperative acute kidney injury...
  51. ncbi Cost-related medication underuse: prevalence among hospitalized managed care patients
    Niteesh K Choudhry
    Department of Medicine, Brigham and Women s Hospital, Boston, MA 02120, USA
    J Hosp Med 7:104-9. 2012
    ..Estimates of cost-related medication underuse come largely from surveys of ambulatory patients. Hospitalized patients may be vulnerable to cost-related underuse and its consequences, but have been subject to little investigation...
  52. ncbi A blueprint for pharmacy benefit managers to increase value
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont St, Ste 3030, Boston, MA 02120, USA
    Am J Manag Care 15:87-93. 2009
    ..Incentives for PBMs to promote value should drive innovation and improve health outcomes...
  53. ncbi The cost-effectiveness of C-reactive protein testing and rosuvastatin treatment for patients with normal cholesterol levels
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02120, USA
    J Am Coll Cardiol 57:784-91. 2011
    ..We sought to evaluate the cost-effectiveness of applying the JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) trial results into clinical practice...
  54. ncbi Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events
    Ashna D K Bowry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    Am J Cardiol 101:960-6. 2008
    ....
  55. ncbi Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review
    Neal A Chatterjee
    Department of Medicine and the Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA 02411, USA
    Circ Arrhythm Electrophysiol 5:68-76. 2012
    ..Additionally, the impact of AVNA in patients with reduced systolic function is of growing interest...
  56. ncbi Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis
    Robert M Hayward
    Department of Medicine and Cardiac Arrhythmia Service, Massachusetts General Hospital Heart Center, Boston, Massachusetts, USA
    Heart Rhythm 8:994-1000. 2011
    ..Ablation of complex fractionated atrial electrograms (CFAEs) in addition to PVI has been advocated as a means to improve procedural outcomes, but the benefit remains unclear...
  57. ncbi Statin utilization in nursing home patients after cardiac hospitalization
    Seema Parikh
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA, USA
    J Gen Intern Med 25:1293-9. 2010
    ..Coronary artery disease (CAD) is highly prevalent in nursing home residents and is associated with a substantial clinical and economic burden. Statins reduce mortality and hospitalization rates in older patients with CAD...
  58. ncbi Patients' perceptions of generic medications
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, at Brigham and Women s Hospital Harvard Medical School in Boston, Massachusetts, USA
    Health Aff (Millwood) 28:546-56. 2009
    ..These findings underscore the challenge that providers, insurers, and policymakers face in stimulating the cost-effective use of medications...
  59. ncbi Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook
    Jeremy A Greene
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA
    J Gen Intern Med 26:287-92. 2011
    ..These new sources of knowledge, support, and engagement have become important for patients living with chronic disease, yet the quality and content of the information provided in these digital arenas are poorly understood...
  60. ncbi Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study
    Jennifer M Polinski
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030, Boston, MA, USA
    BMC Endocr Disord 12:20. 2012
    ..abstract:..
  61. ncbi A systematic review of reference pricing: implications for US prescription drug spending
    Joy Li Yueh Lee
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Am J Manag Care 18:e429-37. 2012
    ..These results suggest that reference pricing may be an attractive policy strategy for the US healthcare system...
  62. ncbi Early angiography in patients with chronic kidney disease: a collaborative systematic review
    David M Charytan
    Renal Division and Clinical Biometrics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 4:1032-43. 2009
    ....
  63. ncbi Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies
    Gaurav A Upadhyay
    Department of Medicine and the Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    J Am Coll Cardiol 52:1239-46. 2008
    ..This study is a meta-analysis of prospective cohort studies comparing the impact of cardiac resynchronization therapy (CRT) for patients in atrial fibrillation (AF) and sinus rhythm (SR)...
  64. ncbi Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
    Niteesh K Choudhry
    Harvard Medical School and Brigham and Women s Hospital, Boston 02120, USA
    BMJ 332:141-5. 2006
    ..To quantify the influence of physicians' experiences of adverse events in patients with atrial fibrillation who were taking warfarin...
  65. ncbi Assessing the evidence for value-based insurance design
    Niteesh K Choudhry
    Harvard Medical School, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
    Health Aff (Millwood) 29:1988-94. 2010
    ..Maximizing the benefits of value-based insurance design will require mechanisms to target appropriate copayment reductions, offset short-run cost outlays, and expand its use to other health services...
  66. ncbi The variability and quality of medication container labels
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont St, Ste 3030, Boston, MA 02120, USA
    Arch Intern Med 167:1760-5. 2007
    ..Medication errors occur frequently, and poor medication labeling is cited as a potential cause. We assessed the format, content, and variability of prescription drug container labels dispensed in the community...
  67. ncbi Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004
    Suzanne M Cadarette
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02120, USA
    J Rheumatol 35:319-26. 2008
    ..To examine trends in osteoporosis drug prescribing after hip fracture from 1995 to 2004...
  68. ncbi Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02120, USA
    Heart 93:945-51. 2007
    ..To compare the effectiveness of statins of different treatment intensity used to treat elderly patients with acute coronary syndrome (ACS) in typical care settings...
  69. ncbi Over-the-counter statins
    Niteesh K Choudhry
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02120, USA
    Ann Intern Med 142:910-3. 2005
    ..quot;..
  70. ncbi The conditional relative odds ratio provided less biased results for comparing diagnostic test accuracy in meta-analyses
    Sadao Suzuki
    Department of Epidemiology, Harvard School of Public Heath, 677 Huntington Avenue, Boston, MA 02115, USA
    J Clin Epidemiol 57:461-9. 2004
    ..The later has received very little attention in the literature, and is the focus of this article...
  71. ncbi Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most?
    William H Shrank
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, Harvard Medical School, 1620 Tremont Street, Ste 3030, Boston, MA 02120, USA
    Am J Manag Care 12:545-51. 2006
    ..We evaluated physicians' perceptions about relevant costs for prescription drugs and the importance of communication about these costs...
  72. ncbi Impact of Medicaid prior authorization on angiotensin-receptor blockers: can policy promote rational prescribing?
    Michael A Fischer
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital Harvard Medical School, Boston, Massachusetts, USA
    Health Aff (Millwood) 26:800-7. 2007
    ..3 percent per quarter; alternative approaches were unsuccessful. These findings have important implications for the development of rational drug reimbursement policy under Medicare Part D and other health insurance plans...
  73. ncbi CPR for patients labeled DNR: the role of the limited aggressive therapy order
    Niteesh K Choudhry
    Harvard University, Cambridge, Massachusetts, USA
    Ann Intern Med 138:65-8. 2003
    ..This new level of resuscitation could be called a "limited aggressive therapy" order...
  74. ncbi A perspective on U.S. drug reimportation
    Niteesh K Choudhry
    Brigham and Women's Hospital
    Minn Med 88:46-51. 2005
  75. ncbi Relationships between authors of clinical practice guidelines and the pharmaceutical industry
    Niteesh K Choudhry
    Mount Sinai Hospital, Room 427, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
    JAMA 287:612-7. 2002
    ..Our study highlights the need for appropriate disclosure of financial conflicts of interest for authors of CPGs and a formal process for discussing these conflicts prior to CPG development...
  76. ncbi Medication adherence after myocardial infarction: a long way left to go
    Niteesh K Choudhry
    J Gen Intern Med 23:216-8. 2008
  77. ncbi Unregulated private markets for health care in Canada? Rules of professional misconduct, physician kickbacks and physician self-referral
    Sujit Choudhry
    Faculty of Law, University of Toronto, ON
    CMAJ 170:1115-8. 2004